Catastrophic antiphospholipid antibody syndrome presenting as acute vascular occlusion in a young female patient

array:23 ["pii" => "S1699258X16301073" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2016.09.002" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "970" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "copyrightAnyo" => "2016" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Reumatol Clin. 2018;14:49-52" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3655 "formatos" => array:3 [ "EPUB" => 141 "HTML" => 2452 "PDF" => 1062 ] ] "itemSiguiente" => array:19 [ "pii" => "S1699258X16301279" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2016.09.005" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "973" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Reumatol Clin. 2018;14:53-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5537 "formatos" => array:3 [ "EPUB" => 190 "HTML" => 4344 "PDF" => 1003 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "Reumatología clínica en imágenes" "titulo" => "Características del componente purpúrico de la urticaria con vasculitis y de la urticaria sin vasculitis" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "53" "paginaFinal" => "55" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Purpuric component features that differentiate urticarial vasculitis and urticaria without vasculitis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1085 "Ancho" => 1447 "Tamanyo" => 204998 ] ] "descripcion" => array:1 [ "es" => "Urticaria prolongada, sin vasculitis leucocitoclástica. Los 4 pacientes tienen al menos una biopsia que muestra la presencia de un infiltrado inflamatorio linfocitario perivascular superficial, con o sin eosinófilos, sin vasculitis. Nótese la presencia de un componente equimótico en el interior de las lesiones agudas (a y b) y sobrepasando los límites de las mismas (c y d)." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Belén Lozano Masdemont, Celia Horcajada Reales, Laura Gómez-Recuero Muñoz, Verónica Parra Blanco" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Belén" "apellidos" => "Lozano Masdemont" ] 1 => array:2 [ "nombre" => "Celia" "apellidos" => "Horcajada Reales" ] 2 => array:2 [ "nombre" => "Laura" "apellidos" => "Gómez-Recuero Muñoz" ] 3 => array:2 [ "nombre" => "Verónica" "apellidos" => "Parra Blanco" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S217357431730117X" "doi" => "10.1016/j.reumae.2016.09.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357431730117X?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16301279?idApp=UINPBA00004M" "url" => "/1699258X/0000001400000001/v2_201802071822/S1699258X16301279/v2_201802071822/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1699258X16301085" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2016.09.003" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "971" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Reumatol Clin. 2018;14:46-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3086 "formatos" => array:3 [ "EPUB" => 131 "HTML" => 1856 "PDF" => 1099 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Case report" "titulo" => "Managing hypertriglyceridemia in children with systemic lupus erythematosus: Two sides of the same coin" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "46" "paginaFinal" => "48" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Manejo de la hipertrigliceridemia en niños con lupus eritematoso sistémico: 2 caras de la misma moneda" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 956 "Ancho" => 1641 "Tamanyo" => 112324 ] ] "descripcion" => array:1 [ "en" => "Serum triglyceride levels over time." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Biswanath Basu, Binu George Babu, Suman Bhattacharyya" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Biswanath" "apellidos" => "Basu" ] 1 => array:2 [ "nombre" => "Binu George" "apellidos" => "Babu" ] 2 => array:2 [ "nombre" => "Suman" "apellidos" => "Bhattacharyya" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16301085?idApp=UINPBA00004M" "url" => "/1699258X/0000001400000001/v2_201802071822/S1699258X16301085/v2_201802071822/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "Case Report" "titulo" => "Catastrophic antiphospholipid antibody syndrome presenting as acute vascular occlusion in a young female patient" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "49" "paginaFinal" => "52" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Joaquín Valle Alonso, Francisco Javier Fonseca del Pozo, Manuel Vaquero Álvarez, Jorge Pedraza, Miguel Angel Aguayo, Almudena Sanchez" "autores" => array:6 [ 0 => array:4 [ "nombre" => "Joaquín Valle" "apellidos" => "Alonso" "email" => array:1 [ 0 => "joa51274@hotmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Francisco Javier Fonseca" "apellidos" => "del Pozo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Manuel Vaquero" "apellidos" => "Álvarez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Jorge" "apellidos" => "Pedraza" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "d" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "Miguel Angel" "apellidos" => "Aguayo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "d" "identificador" => "aff0020" ] ] ] 5 => array:3 [ "nombre" => "Almudena" "apellidos" => "Sanchez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "d" "identificador" => "aff0020" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Royal Bournemouth Hospital, Bournemouth, UK" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Emergency Medicine Montoro, Cordoba, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Unidad Gestión Clínica Linares (Jaén), Centro Salud San José, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Hospital Valle de los Pedroches, Cordoba, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Síndrome de anticuerpos antifosfolípidos catastrófico que se presenta con oclusión vascular aguda en una paciente joven" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1872 "Ancho" => 1395 "Tamanyo" => 337663 ] ] "descripcion" => array:1 [ "en" => "Extensive fresh thrombus is noted in the left inflow, left CFA and the left SFA. Thrombus also noted in the right internal iliac, right profunda and SFA origin. Fresh thrombus noted in the right distal popliteal and trifurcation origin. Multiple splenic and left renal infarcts noted." ] ] ] "textoCompleto" => "IntroductionIn the 1980s and 1990s, some case reports emerged in the literature documenting patients with thrombotic complications, often fatal, associated with the presence of antiphospholipid antibodies. Only in 1992 for the first time, 10 patients with this unusual condition were revisited. The main characteristics of these were properly review in an attempt to define the severity and rapidity of installation and a catastrophic adjective was added to represent this variant of the antiphospholipid syndrome (APS).<a class="elsevierStyleCrossRef" href="#bib0030">1</a> Since then, the term catastrophic antiphospholipid syndrome (CAPS syndrome or Asherson syndrome) was accepted and has been used extensively.Case descriptionWe present a case of a 19-year-old black woman that presented to the Emergency Department with abdominal and left thigh pain. Previous medical and obstetric history included a recent stillbirth 6 weeks ago, at 36 weeks with positive lupus anticoagulant. Recent admission to Hospital due to abdominal pain, seen by Medical and Surgical team that ruled out acute pathology and was referred to Obstetrics service that discharged the patient with further follow-up. At arrival the patient was agitated and uncooperative complaining of abdominal and left thigh pain. The patient reported severe pain in her left leg accompanied by nausea, she did not have chest pain, shortness of breath, fever, chills, dysuria, constipation, or diarrhoea. The temperature was 37.1°C, the pulse was 91, and the respiratory rate 18. The blood pressure was 135/85mmHg. The patient was intermittently agitated. Examination revealed diffusely tender abdomen but not distended; the bowel sounds were normal. Examination of the extremities demonstrated absent pedal pulses on both sides, and a mild sensory loss on the left leg. Morphine sulphate, paracetamol and fluids were administered. A point-of-care ultrasound of lower legs showed the absence of a flow signal suggestive of vascular occlusion.Initially the patient was suspected to have a sickle cell pain crisis however a reviewed of recent blood tests including electrophoresis did not show the presence of homozygous HbS or documented other hemoglobinopathies. Blood tests revealed; Hb 110g/L, WBC 13.6×109/L, Platelets 151×109/L, total bilirubin 5μmol/L, ALT 30U/L, GGT 98U/L, calcium 2.36mmol/L, phosphate 0.95mmol/L, ALP 125U/L, sodium 136mmol/L, potassium 3.4mmol/L, urea 3.0mmol/L, creatinine 83μmol/L (reference range: 0–110), AKI Stage 1, blood gases showed lactic acidosis type A. Increased reticulocytes and free haemoglobin indicated a hemolytic anaemia with scanty schistocytes on peripheral blood smear analysis. Troponin T 61, (reference range: <14) with no ST segment changes on electrocardiography.An emergency CT (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>) was requested that reported extensive fresh thrombus is noted in the left inflow, left common femoral artery and the left superficial femoral artery. Thrombus also noted in the right internal iliac, right profound and superficial femoral artery origin. Fresh thrombus noted in the right distal popliteal and trifurcation origin. Multiple splenic and left renal infarcts noted, a CT brain did not reported acute ischaemic changes. The trachea was intubated, and ventilatory assistance was begun. Vascular surgeons were requested and the patient was operated on: under general anaesthesia, a left iliofemoral embolectomy associated to a fasciotomy, a thrombus was found in the left common iliofemoral vessels. The patient was anticoagulated with warfarin.<elsevierMultimedia ident="fig0005"></elsevierMultimedia>A transthoracic echocardiogram and cardiac MRI were performed and did not detected any proximal source of emboli. Anticardiolipin IgM 9.8 MPLμ/ml, aCL IgM negative (<10), fibrinogen 5.6g/L (1.50–4.00), DRVVT positive lupus anticoagulant. An MRI 3 days after the onset showed axial FLAIR image showed right frontal borderzone infarction. Extensive autoimmune testing looking for autoimmune disorders potentially responsible for thrombotic events were all negative. Patient's clinical features were consistent with CAPS (symptoms presenting in 24h, including multiple renal and splenic infarcts, non-ST elevation myocardial infarction (NSTEMI), acute vascular thrombotic occlusion with arterial thrombi confirmed by pathology and positive lupus anticoagulant on two separate occasions 12 weeks apart) (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Intravenous hydrocortisone 600mg for 5 days was used followed by oral therapy with prednisone with an initial dose of 60mg, she was slowly tapered off prednisone and currently remains off steroid therapy. At 1 year the patient's evolution has been satisfactory, antiphospholipid tests and immunological screens has been performed and remained positive, there were no clinical or serological features of SLE. There was also no evidence of rheumatoid arthritis developing. Anticoagulation with warfarin remains on to date.<elsevierMultimedia ident="tbl0005"></elsevierMultimedia>DiscussionThis case represents a complex medical patient in a busy ED service. Upon arrival it was difficult to obtain a clear history due to her confusion state. Initially her clinical symptoms suggested an acute vaso-occlusive crisis in the context of a suspected non-diagnosed sickle cell anaemia. A bedside ultrasound showed a suspected occlusion of the left lower extremity and the blood tests were not suggestive of sickle cell disease. CT showed multiple thrombotic events and a limb-threatening thrombosis. The positive history of anticardiolipin antibodies and the recent stillbirth suggested the diagnosis of APS. The patient had a successful recovery with a final diagnosis of CPAS syndrome.Clinical manifestations and pathological features present in patients with CAPS syndrome depend mainly on two factors: the organs affected by the thrombotic events (thrombosis extension) and systemic inflammatory response syndrome manifestations.<a class="elsevierStyleCrossRef" href="#bib0035">2</a> The occlusion of medium or large calibre vessels is rare in the CAPS. Dysfunction of multiple organ is due to acute microangiopathy thrombosis affecting small vessels in various organs. Our patient presented with acute lower limb vascular occlusion and multiple splenic and left renal infarcts, acute confusion and NSTEMI. No previous report of life threatening limb vascular occlusion has been reported. The most significant laboratory findings include hemolytic anaemia and thrombocytopenia, hemolytic anaemia has been described in 39% of the patients with most of the cases with positive Coombs test. Coagulation tests shows characteristics of intravascular disseminated coagulation (DIC), such as prolonged prothrombin time and increase in fibrinogen degradation products. Blood smear may reveal schistocytes, that are usually scanty, unlike the abundant numbers seen in patients with thrombotic thrombocytopenic purpura, the meaning of schistocytes is still uncertain. 68% of patients in the two main series of cases show antiphospholipid antibodies. The diagnosis of CAPS can be challenging, and sometimes the differential diagnosis cannot be narrowed to a single disease during the acute period. Thus, continuous assessment of patients is warranted.An interface of HELLP Syndrome and CAPS exists. A series of 15 cases of CAPS, which appeared during pregnancy or the puerperium were described.<a class="elsevierStyleCrossRef" href="#bib0040">3</a> HELLP syndrome occurred in eight (53%) of the patients. Mortality from the obstetric catastrophic CAPS cohort was extraordinarily high, with 46% (seven out of 15) of the mothers and 64% (seven out of 13) of the neonates succumbing to the disease process. Our reported case was diagnosed in the puerperium, although no previous diagnosis of preeclampsia or HELLP syndrome was established. It is important to consider the possibility of the development of CAPS in those patients with signs of HELLP syndrome and multiorgan failure during pregnancy or puerperium, especially in those patients with previous history of abortions and/or thrombosis.Regarding the long term outcome of CAPS survivors; an analysis of 130 patients showed that 66% of patients who survive an initial event remained symptom free with anticoagulation during an average follow up of 67.2 months.<a class="elsevierStyleCrossRef" href="#bib0045">4</a> Treatment with intensive anticoagulation, plasma exchange, and corticosteroids appears beneficial, but no controlled trials have been performed. Intravenous immunoglobulin may be of some benefit, and rituximab or cyclophosphamide may be considered in selected cases, especially in SLE-associated CAPS.ConclusionsPatients with hypercoagulable states presents in EDs with several symptoms and signs including life-threatening conditions,<a class="elsevierStyleCrossRef" href="#bib0050">5</a> the reported case is an example of the complexity of these complex pathologies, therefore emergency physicians should be familiar with the diagnosis and start immediately lifesaving therapies.Ethical disclosuresProtection of human and animal subjectsThe authors declare that the procedures followed were in accordance with the regulations of the relevant clinical research ethics committee and with those of the Code of Ethics of the World Medical Association (Declaration of Helsinki).Confidentiality of dataThe authors declare that they have followed the protocols of their work centre on the publication of patient data.Right to privacy and informed consentThe authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.Conflict of interestThe authors declare they have no conflicts of interests." "textoCompletoSecciones" => array:1 [ "secciones" => array:11 [ 0 => array:3 [ "identificador" => "xres976263" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec945935" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres976262" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec945936" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Case description" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Discussion" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Conclusions" ] 8 => array:3 [ "identificador" => "sec0025" "titulo" => "Ethical disclosures" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0030" "titulo" => "Protection of human and animal subjects" ] 1 => array:2 [ "identificador" => "sec0035" "titulo" => "Confidentiality of data" ] 2 => array:2 [ "identificador" => "sec0040" "titulo" => "Right to privacy and informed consent" ] ] ] 9 => array:2 [ "identificador" => "sec0045" "titulo" => "Conflict of interest" ] 10 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2016-08-04" "fechaAceptado" => "2016-09-08" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec945935" "palabras" => array:3 [ 0 => "Antiphospholipid syndrome" 1 => "Asherson syndrome" 2 => "Catastrophic antiphospholipid syndrome" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec945936" "palabras" => array:3 [ 0 => "Síndrome antifosfolípido" 1 => "Síndrome de Asherson" 2 => "Síndrome antifosfolípido catastrófico" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "Acquired thrombotic and thromboembolic disorders may be presented initially with symptoms and signs of acute ischaemia or organ dysfunction that will lead many of these patients to seek care in the emergency department. We report a case of a 19-year-old female patient who developed catastrophic antiphospholipid syndrome (CAPS syndrome or Asherson syndrome) 6 weeks post stillbirth with an initial presentation of acute vascular occlusion. The patient was immediately operated and anticoagulated with significant improvement." ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "Los trastornos trombóticos y tromboembólicos adquiridos pueden manifestarse inicialmente con signos y síntomas de isquemia aguda o disfunción orgánica que derivará a muchos de estos pacientes al servicio de urgencias. Se presenta el caso de una paciente de 19 años de edad que desarrolló un síndrome antifosfolípido catastrófico (o síndrome de Asherson) 6 semanas después del parto de un feto muerto con una presentación inicial de oclusión vascular aguda. La paciente fue intervenida inmediatamente y se inició un tratamiento con anticoagulantes que supuso una mejora significativa." ] ] "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1872 "Ancho" => 1395 "Tamanyo" => 337663 ] ] "descripcion" => array:1 [ "en" => "Extensive fresh thrombus is noted in the left inflow, left CFA and the left SFA. Thrombus also noted in the right internal iliac, right profunda and SFA origin. Fresh thrombus noted in the right distal popliteal and trifurcation origin. Multiple splenic and left renal infarcts noted." ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">1. Evidence of involvement of three or more organs, systems and/or tissues \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">2. Development of manifestations simultaneously or in less than a week \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">3. Confirmation by histopathology of small-vessel occlusion<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">4 Laboratory confirmation of the presence of antiphospholipid antibodies<a class="elsevierStyleCrossRef" href="#tblfn0010">b</a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Definite catastrophic antiphospholipid syndrome \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">• All four criteria present \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Probable catastrophic antiphospholipid syndrome \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">• All four criteria, except only two organs, systems, and/or tissues involved \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">• All four criteria, except for the absence of laboratory confirmation of antiphospholipid antibodies \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">• Criteria 1, 2, and 4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">• Criteria 1, 3, and 4, with the development of a third event more than 1 week but within 1 month of presentation, despite anticoagulation \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1653397.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "Vasculitis may coexist, but significant thrombosis must be present as well." ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "b" "nota" => "“Positive aPL” twice 12 weeks apart (of note, the original Sapporo APS classification criteria required two positive aPL tests 6 weeks apart, which has been changed to 12 weeks as part of the updated Sapporo APS classification criteria." ] ] ] "descripcion" => array:1 [ "en" => "Preliminary classification criteria for catastrophic antiphospholipid syndrome." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The catastrophic antiphospholipid syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R.A. Asherson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Rheumatol" "fecha" => "1992" "volumen" => "19" "paginaInicial" => "508" "paginaFinal" => "512" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1593568" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "CAPS Registry" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R. Cervera" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203312436866" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2012" "volumen" => "21" "paginaInicial" => "755" "paginaFinal" => "757" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22635223" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.A. Gomez-Puerta" 1 => "R. Cervera" 2 => "G. Espinosa" 3 => "R.A. Asherson" 4 => "M. Garcia Carrasco" 5 => "I.P. da Costa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/ard.2006.061671" "Revista" => array:7 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2007" "volumen" => "66" "paginaInicial" => "740" "paginaFinal" => "746" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17223653" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0735675715005355" "estado" => "S300" "issn" => "07356757" ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long term outcome of catastrophic antiphospholipid syndrome survivors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Erkan" 1 => "R.A. Asherson" 2 => "G. Espinosa" 3 => "R. Cervera" 4 => "J. Font" 5 => "J.-C. Piette" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2003" "volumen" => "62" "paginaInicial" => "530" "paginaFinal" => "533" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12759289" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute thrombotic disorders" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.G. Kuntz" 1 => "J.D. Cheesman" 2 => "R.D. Powers" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ajem.2006.01.009" "Revista" => array:7 [ "tituloSerie" => "Am J Emerg Med" "fecha" => "2006" "volumen" => "24" "paginaInicial" => "460" "paginaFinal" => "467" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16787806" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0952818014003365" "estado" => "S300" "issn" => "09528180" ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/1699258X/0000001400000001/v2_201802071822/S1699258X16301073/v2_201802071822/en/main.assets" "Apartado" => array:4 [ "identificador" => "33643" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Casos clínicos" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/1699258X/0000001400000001/v2_201802071822/S1699258X16301073/v2_201802071822/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16301073?idApp=UINPBA00004M"]

Estadísticas

Case Report

Catastrophic antiphospholipid antibody syndrome presenting as acute vascular occlusion in a young female patient

Síndrome de anticuerpos antifosfolípidos catastrófico que se presenta con oclusión vascular aguda en una paciente joven

Joaquín Valle Alonsoa,

Autor para correspondencia

joa51274@hotmail.com

Corresponding author.

, Francisco Javier Fonseca del Pozob, Manuel Vaquero Álvarezc, Jorge Pedrazad, Miguel Angel Aguayod, Almudena Sanchezd

a Royal Bournemouth Hospital, Bournemouth, UK

b Emergency Medicine Montoro, Cordoba, Spain

c Unidad Gestión Clínica Linares (Jaén), Centro Salud San José, Spain

d Hospital Valle de los Pedroches, Cordoba, Spain

Leído

12383

Veces
se ha leído el artículo

3412

Total PDF

8971

Total HTML

Compartir estadísticas

 array:23 [
  "pii" => "S1699258X16301073"
  "issn" => "1699258X"
  "doi" => "10.1016/j.reuma.2016.09.002"
  "estado" => "S300"
  "fechaPublicacion" => "2018-01-01"
  "aid" => "970"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
  "copyrightAnyo" => "2016"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "cita" => "Reumatol Clin. 2018;14:49-52"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3655
    "formatos" => array:3 [
      "EPUB" => 141
      "HTML" => 2452
      "PDF" => 1062
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1699258X16301279"
    "issn" => "1699258X"
    "doi" => "10.1016/j.reuma.2016.09.005"
    "estado" => "S300"
    "fechaPublicacion" => "2018-01-01"
    "aid" => "973"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Reumatol Clin. 2018;14:53-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 5537
      "formatos" => array:3 [
        "EPUB" => 190
        "HTML" => 4344
        "PDF" => 1003
      ]
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Reumatolog&#237;a cl&#237;nica en im&#225;genes</span>"
      "titulo" => "Caracter&#237;sticas del componente purp&#250;rico de la urticaria con vasculitis y de la urticaria sin vasculitis"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "53"
          "paginaFinal" => "55"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Purpuric component features that differentiate urticarial vasculitis and urticaria without vasculitis"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figura 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 1085
              "Ancho" => 1447
              "Tamanyo" => 204998
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Urticaria prolongada&#44; sin vasculitis leucocitocl&#225;stica&#46; Los 4 pacientes tienen al menos una biopsia que muestra la presencia de un infiltrado inflamatorio linfocitario perivascular superficial&#44; con o sin eosin&#243;filos&#44; sin vasculitis&#46; N&#243;tese la presencia de un componente equim&#243;tico en el interior de las lesiones agudas &#40;a y b&#41; y sobrepasando los l&#237;mites de las mismas &#40;c y d&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Bel&#233;n Lozano Masdemont, Celia Horcajada Reales, Laura G&#243;mez-Recuero Mu&#241;oz, Ver&#243;nica Parra Blanco"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Bel&#233;n"
              "apellidos" => "Lozano Masdemont"
            ]
            1 => array:2 [
              "nombre" => "Celia"
              "apellidos" => "Horcajada Reales"
            ]
            2 => array:2 [
              "nombre" => "Laura"
              "apellidos" => "G&#243;mez-Recuero Mu&#241;oz"
            ]
            3 => array:2 [
              "nombre" => "Ver&#243;nica"
              "apellidos" => "Parra Blanco"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S217357431730117X"
        "doi" => "10.1016/j.reumae.2016.09.003"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357431730117X?idApp=UINPBA00004M"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16301279?idApp=UINPBA00004M"
    "url" => "/1699258X/0000001400000001/v2_201802071822/S1699258X16301279/v2_201802071822/es/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S1699258X16301085"
    "issn" => "1699258X"
    "doi" => "10.1016/j.reuma.2016.09.003"
    "estado" => "S300"
    "fechaPublicacion" => "2018-01-01"
    "aid" => "971"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Reumatol Clin. 2018;14:46-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3086
      "formatos" => array:3 [
        "EPUB" => 131
        "HTML" => 1856
        "PDF" => 1099
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>"
      "titulo" => "Managing hypertriglyceridemia in children with systemic lupus erythematosus&#58; Two sides of the same coin"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "46"
          "paginaFinal" => "48"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Manejo de la hipertrigliceridemia en ni&#241;os con lupus eritematoso sist&#233;mico&#58; 2 caras de la misma moneda"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 956
              "Ancho" => 1641
              "Tamanyo" => 112324
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Serum triglyceride levels over time&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Biswanath Basu, Binu George Babu, Suman Bhattacharyya"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Biswanath"
              "apellidos" => "Basu"
            ]
            1 => array:2 [
              "nombre" => "Binu George"
              "apellidos" => "Babu"
            ]
            2 => array:2 [
              "nombre" => "Suman"
              "apellidos" => "Bhattacharyya"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16301085?idApp=UINPBA00004M"
    "url" => "/1699258X/0000001400000001/v2_201802071822/S1699258X16301085/v2_201802071822/en/main.assets"
  ]
  "en" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>"
    "titulo" => "Catastrophic antiphospholipid antibody syndrome presenting as acute vascular occlusion in a young female patient"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "49"
        "paginaFinal" => "52"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Joaqu&#237;n Valle Alonso, Francisco Javier Fonseca del Pozo, Manuel Vaquero &#193;lvarez, Jorge Pedraza, Miguel Angel Aguayo, Almudena Sanchez"
        "autores" => array:6 [
          0 => array:4 [
            "nombre" => "Joaqu&#237;n Valle"
            "apellidos" => "Alonso"
            "email" => array:1 [
              0 => "joa51274&#64;hotmail&#46;com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Francisco Javier Fonseca"
            "apellidos" => "del Pozo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Manuel Vaquero"
            "apellidos" => "&#193;lvarez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Jorge"
            "apellidos" => "Pedraza"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Miguel Angel"
            "apellidos" => "Aguayo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Almudena"
            "apellidos" => "Sanchez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:4 [
          0 => array:3 [
            "entidad" => "Royal Bournemouth Hospital&#44; Bournemouth&#44; UK"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Emergency Medicine Montoro&#44; Cordoba&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Unidad Gesti&#243;n Cl&#237;nica Linares &#40;Ja&#233;n&#41;&#44; Centro Salud San Jos&#233;&#44; Spain"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "Hospital Valle de los Pedroches&#44; Cordoba&#44; Spain"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "S&#237;ndrome de anticuerpos antifosfol&#237;pidos catastr&#243;fico que se presenta con oclusi&#243;n vascular aguda en una paciente joven"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1872
            "Ancho" => 1395
            "Tamanyo" => 337663
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Extensive fresh thrombus is noted in the left inflow&#44; left CFA and the left SFA&#46; Thrombus also noted in the right internal iliac&#44; right profunda and SFA origin&#46; Fresh thrombus noted in the right distal popliteal and trifurcation origin&#46; Multiple splenic and left renal infarcts noted&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">In the 1980s and 1990s&#44; some case reports emerged in the literature documenting patients with thrombotic complications&#44; often fatal&#44; associated with the presence of antiphospholipid antibodies&#46; Only in 1992 for the first time&#44; 10 patients with this unusual condition were revisited&#46; The main characteristics of these were properly review in an attempt to define the severity and rapidity of installation and a catastrophic adjective was added to represent this variant of the antiphospholipid syndrome &#40;APS&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> Since then&#44; the term catastrophic antiphospholipid syndrome &#40;CAPS syndrome or Asherson syndrome&#41; was accepted and has been used extensively&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Case description</span><p id="par0010" class="elsevierStylePara elsevierViewall">We present a case of a 19-year-old black woman that presented to the Emergency Department with abdominal and left thigh pain&#46; Previous medical and obstetric history included a recent stillbirth 6 weeks ago&#44; at 36 weeks with positive lupus anticoagulant&#46; Recent admission to Hospital due to abdominal pain&#44; seen by Medical and Surgical team that ruled out acute pathology and was referred to Obstetrics service that discharged the patient with further follow-up&#46; At arrival the patient was agitated and uncooperative complaining of abdominal and left thigh pain&#46; The patient reported severe pain in her left leg accompanied by nausea&#44; she did not have chest pain&#44; shortness of breath&#44; fever&#44; chills&#44; dysuria&#44; constipation&#44; or diarrhoea&#46; The temperature was 37&#46;1<span class="elsevierStyleHsp" style=""></span>&#176;C&#44; the pulse was 91&#44; and the respiratory rate 18&#46; The blood pressure was 135&#47;85<span class="elsevierStyleHsp" style=""></span>mmHg&#46; The patient was intermittently agitated&#46; Examination revealed diffusely tender abdomen but not distended&#59; the bowel sounds were normal&#46; Examination of the extremities demonstrated absent pedal pulses on both sides&#44; and a mild sensory loss on the left leg&#46; Morphine sulphate&#44; paracetamol and fluids were administered&#46; A point-of-care ultrasound of lower legs showed the absence of a flow signal suggestive of vascular occlusion&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Initially the patient was suspected to have a sickle cell pain crisis however a reviewed of recent blood tests including electrophoresis did not show the presence of homozygous HbS or documented other hemoglobinopathies&#46; Blood tests revealed&#59; Hb 110<span class="elsevierStyleHsp" style=""></span>g&#47;L&#44; WBC 13&#46;6<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">9</span>&#47;L&#44; Platelets 151<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">9</span>&#47;L&#44; total bilirubin 5<span class="elsevierStyleHsp" style=""></span>&#956;mol&#47;L&#44; ALT 30<span class="elsevierStyleHsp" style=""></span>U&#47;L&#44; GGT 98<span class="elsevierStyleHsp" style=""></span>U&#47;L&#44; calcium 2&#46;36<span class="elsevierStyleHsp" style=""></span>mmol&#47;L&#44; phosphate 0&#46;95<span class="elsevierStyleHsp" style=""></span>mmol&#47;L&#44; ALP 125<span class="elsevierStyleHsp" style=""></span>U&#47;L&#44; sodium 136<span class="elsevierStyleHsp" style=""></span>mmol&#47;L&#44; potassium 3&#46;4<span class="elsevierStyleHsp" style=""></span>mmol&#47;L&#44; urea 3&#46;0<span class="elsevierStyleHsp" style=""></span>mmol&#47;L&#44; creatinine 83<span class="elsevierStyleHsp" style=""></span>&#956;mol&#47;L &#40;reference range&#58; 0&#8211;110&#41;&#44; AKI Stage 1&#44; blood gases showed lactic acidosis type A&#46; Increased reticulocytes and free haemoglobin indicated a hemolytic anaemia with scanty schistocytes on peripheral blood smear analysis&#46; Troponin T 61&#44; &#40;reference range&#58; &#60;14&#41; with no ST segment changes on electrocardiography&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">An emergency CT &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41; was requested that reported extensive fresh thrombus is noted in the left inflow&#44; left common femoral artery and the left superficial femoral artery&#46; Thrombus also noted in the right internal iliac&#44; right profound and superficial femoral artery origin&#46; Fresh thrombus noted in the right distal popliteal and trifurcation origin&#46; Multiple splenic and left renal infarcts noted&#44; a CT brain did not reported acute ischaemic changes&#46; The trachea was intubated&#44; and ventilatory assistance was begun&#46; Vascular surgeons were requested and the patient was operated on&#58; under general anaesthesia&#44; a left iliofemoral embolectomy associated to a fasciotomy&#44; a thrombus was found in the left common iliofemoral vessels&#46; The patient was anticoagulated with warfarin&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">A transthoracic echocardiogram and cardiac MRI were performed and did not detected any proximal source of emboli&#46; Anticardiolipin IgM 9&#46;8 MPL<span class="elsevierStyleHsp" style=""></span>&#956;&#47;ml&#44; aCL IgM negative &#40;&#60;10&#41;&#44; fibrinogen 5&#46;6<span class="elsevierStyleHsp" style=""></span>g&#47;L &#40;1&#46;50&#8211;4&#46;00&#41;&#44; DRVVT positive lupus anticoagulant&#46; An MRI 3 days after the onset showed axial FLAIR image showed right frontal borderzone infarction&#46; Extensive autoimmune testing looking for autoimmune disorders potentially responsible for thrombotic events were all negative&#46; Patient&#39;s clinical features were consistent with CAPS &#40;symptoms presenting in 24<span class="elsevierStyleHsp" style=""></span>h&#44; including multiple renal and splenic infarcts&#44; non-ST elevation myocardial infarction &#40;NSTEMI&#41;&#44; acute vascular thrombotic occlusion with arterial thrombi confirmed by pathology and positive lupus anticoagulant on two separate occasions 12 weeks apart&#41; &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; Intravenous hydrocortisone 600<span class="elsevierStyleHsp" style=""></span>mg for 5 days was used followed by oral therapy with prednisone with an initial dose of 60<span class="elsevierStyleHsp" style=""></span>mg&#44; she was slowly tapered off prednisone and currently remains off steroid therapy&#46; At 1 year the patient&#39;s evolution has been satisfactory&#44; antiphospholipid tests and immunological screens has been performed and remained positive&#44; there were no clinical or serological features of SLE&#46; There was also no evidence of rheumatoid arthritis developing&#46; Anticoagulation with warfarin remains on to date&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Discussion</span><p id="par0030" class="elsevierStylePara elsevierViewall">This case represents a complex medical patient in a busy ED service&#46; Upon arrival it was difficult to obtain a clear history due to her confusion state&#46; Initially her clinical symptoms suggested an acute vaso-occlusive crisis in the context of a suspected non-diagnosed sickle cell anaemia&#46; A bedside ultrasound showed a suspected occlusion of the left lower extremity and the blood tests were not suggestive of sickle cell disease&#46; CT showed multiple thrombotic events and a limb-threatening thrombosis&#46; The positive history of anticardiolipin antibodies and the recent stillbirth suggested the diagnosis of APS&#46; The patient had a successful recovery with a final diagnosis of CPAS syndrome&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Clinical manifestations and pathological features present in patients with CAPS syndrome depend mainly on two factors&#58; the organs affected by the thrombotic events &#40;thrombosis extension&#41; and systemic inflammatory response syndrome manifestations&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> The occlusion of medium or large calibre vessels is rare in the CAPS&#46; Dysfunction of multiple organ is due to acute microangiopathy thrombosis affecting small vessels in various organs&#46; Our patient presented with acute lower limb vascular occlusion and multiple splenic and left renal infarcts&#44; acute confusion and NSTEMI&#46; No previous report of life threatening limb vascular occlusion has been reported&#46; The most significant laboratory findings include hemolytic anaemia and thrombocytopenia&#44; hemolytic anaemia has been described in 39&#37; of the patients with most of the cases with positive Coombs test&#46; Coagulation tests shows characteristics of intravascular disseminated coagulation &#40;DIC&#41;&#44; such as prolonged prothrombin time and increase in fibrinogen degradation products&#46; Blood smear may reveal schistocytes&#44; that are usually scanty&#44; unlike the abundant numbers seen in patients with thrombotic thrombocytopenic purpura&#44; the meaning of schistocytes is still uncertain&#46; 68&#37; of patients in the two main series of cases show antiphospholipid antibodies&#46; The diagnosis of CAPS can be challenging&#44; and sometimes the differential diagnosis cannot be narrowed to a single disease during the acute period&#46; Thus&#44; continuous assessment of patients is warranted&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">An interface of HELLP Syndrome and CAPS exists&#46; A series of 15 cases of CAPS&#44; which appeared during pregnancy or the puerperium were described&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> HELLP syndrome occurred in eight &#40;53&#37;&#41; of the patients&#46; Mortality from the obstetric catastrophic CAPS cohort was extraordinarily high&#44; with 46&#37; &#40;seven out of 15&#41; of the mothers and 64&#37; &#40;seven out of 13&#41; of the neonates succumbing to the disease process&#46; Our reported case was diagnosed in the puerperium&#44; although no previous diagnosis of preeclampsia or HELLP syndrome was established&#46; It is important to consider the possibility of the development of CAPS in those patients with signs of HELLP syndrome and multiorgan failure during pregnancy or puerperium&#44; especially in those patients with previous history of abortions and&#47;or thrombosis&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Regarding the long term outcome of CAPS survivors&#59; an analysis of 130 patients showed that 66&#37; of patients who survive an initial event remained symptom free with anticoagulation during an average follow up of 67&#46;2 months&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> Treatment with intensive anticoagulation&#44; plasma exchange&#44; and corticosteroids appears beneficial&#44; but no controlled trials have been performed&#46; Intravenous immunoglobulin may be of some benefit&#44; and rituximab or cyclophosphamide may be considered in selected cases&#44; especially in SLE-associated CAPS&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conclusions</span><p id="par0050" class="elsevierStylePara elsevierViewall">Patients with hypercoagulable states presents in EDs with several symptoms and signs including life-threatening conditions&#44;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> the reported case is an example of the complexity of these complex pathologies&#44; therefore emergency physicians should be familiar with the diagnosis and start immediately lifesaving therapies&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Ethical disclosures</span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Protection of human and animal subjects</span><p id="par0055" class="elsevierStylePara elsevierViewall">The authors declare that the procedures followed were in accordance with the regulations of the relevant clinical research ethics committee and with those of the Code of Ethics of the World Medical Association &#40;Declaration of Helsinki&#41;&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Confidentiality of data</span><p id="par0060" class="elsevierStylePara elsevierViewall">The authors declare that they have followed the protocols of their work centre on the publication of patient data&#46;</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Right to privacy and informed consent</span><p id="par0065" class="elsevierStylePara elsevierViewall">The authors have obtained the written informed consent of the patients or subjects mentioned in the article&#46; The corresponding author is in possession of this document&#46;</p></span></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Conflict of interest</span><p id="par0070" class="elsevierStylePara elsevierViewall">The authors declare they have no conflicts of interests&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:11 [
        0 => array:3 [
          "identificador" => "xres976263"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec945935"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres976262"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec945936"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Case description"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Discussion"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Conclusions"
        ]
        8 => array:3 [
          "identificador" => "sec0025"
          "titulo" => "Ethical disclosures"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "Protection of human and animal subjects"
            ]
            1 => array:2 [
              "identificador" => "sec0035"
              "titulo" => "Confidentiality of data"
            ]
            2 => array:2 [
              "identificador" => "sec0040"
              "titulo" => "Right to privacy and informed consent"
            ]
          ]
        ]
        9 => array:2 [
          "identificador" => "sec0045"
          "titulo" => "Conflict of interest"
        ]
        10 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2016-08-04"
    "fechaAceptado" => "2016-09-08"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec945935"
          "palabras" => array:3 [
            0 => "Antiphospholipid syndrome"
            1 => "Asherson syndrome"
            2 => "Catastrophic antiphospholipid syndrome"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec945936"
          "palabras" => array:3 [
            0 => "S&#237;ndrome antifosfol&#237;pido"
            1 => "S&#237;ndrome de Asherson"
            2 => "S&#237;ndrome antifosfol&#237;pido catastr&#243;fico"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Acquired thrombotic and thromboembolic disorders may be presented initially with symptoms and signs of acute ischaemia or organ dysfunction that will lead many of these patients to seek care in the emergency department&#46; We report a case of a 19-year-old female patient who developed catastrophic antiphospholipid syndrome &#40;CAPS syndrome or Asherson syndrome&#41; 6 weeks post stillbirth with an initial presentation of acute vascular occlusion&#46; The patient was immediately operated and anticoagulated with significant improvement&#46;</p></span>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Los trastornos tromb&#243;ticos y tromboemb&#243;licos adquiridos pueden manifestarse inicialmente con signos y s&#237;ntomas de isquemia aguda o disfunci&#243;n org&#225;nica que derivar&#225; a muchos de estos pacientes al servicio de urgencias&#46; Se presenta el caso de una paciente de 19 a&#241;os de edad que desarroll&#243; un s&#237;ndrome antifosfol&#237;pido catastr&#243;fico &#40;o s&#237;ndrome de Asherson&#41; 6 semanas despu&#233;s del parto de un feto muerto con una presentaci&#243;n inicial de oclusi&#243;n vascular aguda&#46; La paciente fue intervenida inmediatamente y se inici&#243; un tratamiento con anticoagulantes que supuso una mejora significativa&#46;</p></span>"
      ]
    ]
    "multimedia" => array:2 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1872
            "Ancho" => 1395
            "Tamanyo" => 337663
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Extensive fresh thrombus is noted in the left inflow&#44; left CFA and the left SFA&#46; Thrombus also noted in the right internal iliac&#44; right profunda and SFA origin&#46; Fresh thrombus noted in the right distal popliteal and trifurcation origin&#46; Multiple splenic and left renal infarcts noted&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">1&#46; Evidence of involvement of three or more organs&#44; systems and&#47;or tissues&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">2&#46; Development of manifestations simultaneously or in less than a week&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">3&#46; Confirmation by histopathology of small-vessel occlusion<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">4 Laboratory confirmation of the presence of antiphospholipid antibodies<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Definite catastrophic antiphospholipid syndrome</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#8226; All four criteria present&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Probable catastrophic antiphospholipid syndrome</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#8226; All four criteria&#44; except only two organs&#44; systems&#44; and&#47;or tissues involved&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#8226; All four criteria&#44; except for the absence of laboratory confirmation of antiphospholipid antibodies&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#8226; Criteria 1&#44; 2&#44; and 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#8226; Criteria 1&#44; 3&#44; and 4&#44; with the development of a third event more than 1 week but within 1 month of presentation&#44; despite anticoagulation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1653397.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Vasculitis may coexist&#44; but significant thrombosis must be present as well&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0010">&#8220;Positive aPL&#8221; twice 12 weeks apart &#40;of note&#44; the original Sapporo APS classification criteria required two positive aPL tests 6 weeks apart&#44; which has been changed to 12 weeks as part of the updated Sapporo APS classification criteria&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Preliminary classification criteria for catastrophic antiphospholipid syndrome&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The catastrophic antiphospholipid syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "R&#46;A&#46; Asherson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "1992"
                        "volumen" => "19"
                        "paginaInicial" => "508"
                        "paginaFinal" => "512"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1593568"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "CAPS Registry"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "R&#46; Cervera"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/0961203312436866"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lupus"
                        "fecha" => "2012"
                        "volumen" => "21"
                        "paginaInicial" => "755"
                        "paginaFinal" => "757"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22635223"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Catastrophic antiphospholipid syndrome during pregnancy and puerperium&#58; maternal and fetal characteristics of 15 cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;A&#46; Gomez-Puerta"
                            1 => "R&#46; Cervera"
                            2 => "G&#46; Espinosa"
                            3 => "R&#46;A&#46; Asherson"
                            4 => "M&#46; Garcia Carrasco"
                            5 => "I&#46;P&#46; da Costa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/ard.2006.061671"
                      "Revista" => array:7 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2007"
                        "volumen" => "66"
                        "paginaInicial" => "740"
                        "paginaFinal" => "746"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17223653"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0735675715005355"
                          "estado" => "S300"
                          "issn" => "07356757"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long term outcome of catastrophic antiphospholipid syndrome survivors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46; Erkan"
                            1 => "R&#46;A&#46; Asherson"
                            2 => "G&#46; Espinosa"
                            3 => "R&#46; Cervera"
                            4 => "J&#46; Font"
                            5 => "J&#46;-C&#46; Piette"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2003"
                        "volumen" => "62"
                        "paginaInicial" => "530"
                        "paginaFinal" => "533"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12759289"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Acute thrombotic disorders"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46;G&#46; Kuntz"
                            1 => "J&#46;D&#46; Cheesman"
                            2 => "R&#46;D&#46; Powers"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ajem.2006.01.009"
                      "Revista" => array:7 [
                        "tituloSerie" => "Am J Emerg Med"
                        "fecha" => "2006"
                        "volumen" => "24"
                        "paginaInicial" => "460"
                        "paginaFinal" => "467"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16787806"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0952818014003365"
                          "estado" => "S300"
                          "issn" => "09528180"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/1699258X/0000001400000001/v2_201802071822/S1699258X16301073/v2_201802071822/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "33643"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Casos cl&#237;nicos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/1699258X/0000001400000001/v2_201802071822/S1699258X16301073/v2_201802071822/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16301073?idApp=UINPBA00004M"
]

Información del artículo

ISSN: 1699258X
Idioma original: Inglés

DOI:10.1016/j.reuma.2016.09.002

Datos actualizados diariamente

año/Mes	Html	Pdf	Total

2024 Noviembre	6	3	9
2024 Octubre	77	34	111
2024 Septiembre	92	18	110
2024 Agosto	106	44	150
2024 Julio	75	29	104
2024 Junio	83	33	116
2024 Mayo	83	29	112
2024 Abril	72	32	104
2024 Marzo	75	36	111
2024 Febrero	55	30	85
2024 Enero	62	24	86
2023 Diciembre	71	35	106
2023 Noviembre	59	22	81
2023 Octubre	69	35	104
2023 Septiembre	88	38	126
2023 Agosto	41	14	55
2023 Julio	73	27	100
2023 Junio	71	23	94
2023 Mayo	64	30	94
2023 Abril	79	12	91
2023 Marzo	101	32	133
2023 Febrero	80	28	108
2023 Enero	74	14	88
2022 Diciembre	107	68	175
2022 Noviembre	121	49	170
2022 Octubre	143	39	182
2022 Septiembre	106	53	159
2022 Agosto	133	58	191
2022 Julio	91	44	135
2022 Junio	106	50	156
2022 Mayo	126	54	180
2022 Abril	172	63	235
2022 Marzo	157	68	225
2022 Febrero	140	44	184
2022 Enero	138	71	209
2021 Diciembre	101	62	163
2021 Noviembre	119	49	168
2021 Octubre	187	56	243
2021 Septiembre	90	59	149
2021 Agosto	85	56	141
2021 Julio	82	43	125
2021 Junio	83	51	134
2021 Mayo	93	51	144
2021 Abril	367	161	528
2021 Marzo	315	74	389
2021 Febrero	265	39	304
2021 Enero	117	32	149
2020 Diciembre	91	41	132
2020 Noviembre	129	27	156
2020 Octubre	109	22	131
2020 Septiembre	116	63	179
2020 Agosto	175	35	210
2020 Julio	119	17	136
2020 Junio	141	34	175
2020 Mayo	164	33	197
2020 Abril	139	17	156
2020 Marzo	175	33	208
2020 Febrero	191	27	218
2020 Enero	114	31	145
2019 Diciembre	137	33	170
2019 Noviembre	102	25	127
2019 Octubre	149	27	176
2019 Septiembre	126	34	160
2019 Agosto	87	14	101
2019 Julio	90	22	112
2019 Junio	69	27	96
2019 Mayo	136	48	184
2019 Abril	78	35	113
2019 Marzo	138	32	170
2019 Febrero	43	17	60
2019 Enero	68	40	108
2018 Diciembre	121	63	184
2018 Noviembre	231	33	264
2018 Octubre	153	34	187
2018 Septiembre	41	27	68
2018 Agosto	32	10	42
2018 Julio	31	10	41
2018 Junio	0	1	1
2018 Marzo	76	32	108
2018 Febrero	208	133	341
2018 Enero	92	48	140
2017 Diciembre	0	11	11
2017 Noviembre	0	5	5
2017 Octubre	0	9	9
2017 Septiembre	0	13	13
2017 Agosto	0	10	10
2017 Julio	0	12	12
2017 Junio	0	11	11
2017 Mayo	0	15	15
2017 Abril	0	25	25
2017 Marzo	0	16	16
2017 Febrero	0	9	9
2017 Enero	0	18	18
2016 Diciembre	0	32	32
2016 Noviembre	0	37	37
2016 Octubre	0	48	48

Mostrar todo

Indexada en:

Síguenos:

Suscribirse:

Estadísticas

Indexada en:

Síguenos:

Suscribirse:

Estadísticas

Suscríbase a la newsletter